期刊文献+

金属基质蛋白酶9对急性脑梗死病情进展预测意义的研究 被引量:2

Prediction significance of matrix metalloproteinase-9 in the progress of acute cerebral infarction
下载PDF
导出
摘要 目的探讨金属基质蛋白酶9(MMP-9)对急性脑梗死病情进展的预测作用。方法收集40例急性脑梗死患者,稳定型脑梗死组20例,进展型脑梗死组20例,采用酶联免疫吸附法检测入院时血清中MMP-9含量,分析其与病情进展的关系。结果进展型脑梗死组MMP-9含量高于稳定型脑梗死组,MMP-9高值组进展率明显高于低值组。结论入院时血清MMP-9含量可作为评估急性脑梗死病情进展的一项指标。 Objective To evaluate the prediction significance of matrix metalloproteinase-9(MMP-9) in the progress of acute cerebral infarction.Methods Forty acute ischemic stroke patients were enrolled,including 20 patients in stable cerebral infarction group,and 20 patients in progressive cerebral infarction group.The serum specimens were gathered for MMP-9 determination with ELISA on admission to define their potential roles in the progressive cerebral infarction.Results Serum MMP-9 levels in the progressive cerebral infarction group were higher than those in the stable cerebral infarction group.The progressive ratio in the serum MMP-9〉140 ng/mL was significantly higher than that in the serum MMP-9 ≤140 ng/mL.Conclusion MMP-9 levels on admission would be an important evaluating index of the progress of acute cerebral infarction.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2010年第3期277-278,282,共3页 Journal of Harbin Medical University
关键词 金属基质蛋白酶-9 稳定型脑梗死 进展型脑梗死 matrix metallooproteinase-9 stable cerebral infarction progressive cerebral infarction
  • 相关文献

参考文献9

  • 1Zoppo J,Mabuchi T.Cerebral microvessel responses to focal isehemia[J].Cereb Blood Flow Metab,2003,23(8):879-886.
  • 2Serena J,Blanco M,Castellanos M,et al.The prediction of malignant cerebral infarction by molecular brain barrier disruption markers[J].Stroke,2005,36(6):1921-1926.
  • 3Castellanos M,Leira R,Serena J,et al.Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke[J].Stroke,2003,34(5):40-46.
  • 4Maier M,Hsieh L,Yu F,et al.Matrix metallop roteinase-9 and myeloperoxidase expression:quantitative analysis by antigen immunnhistochemistry in a model of transient focal cerebral ischemia[J].Stroke,2004,35(2):1169-1174.
  • 5Rosell A,Ortega-Aznar A,Alvarez-Sabin J,et al.Increased brainexpression of matrix metalloproteinase-9 after isehemie and hemorrhagic human stroke[J].Stroke,2006.37(6):1399-1406.
  • 6Asahi M,Wang X,Mori T.Effects of matrix metalloproteinase-9 gene knock-out on the pmteolysis of blood-brain barrier and white matter components after cerebral ischemia[J].Neuro Sci,2001,21(3):7724-7732.
  • 7Rosenberg GA,NavratilM,Barone F.Proteolytie cascade enzymes increase in focal cerebral ischemia in rat[J].Cereb Blood Flow Metab,1996,16(5):360-366.
  • 8王新,黄如训,曾进胜.脑梗死急性期血清MMP-9的动态变化及其与脑梗死分型关系的研究[J].中国神经精神疾病杂志,2005,31(1):20-23. 被引量:48
  • 9Montaner J,Alarez-Sabin J,Molina CA,et al.Matrix metallopmteinase expression after human cardioemboLic stroke[J].Stroke,2001,32(8):1759-1763.

二级参考文献8

  • 1del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab, 2003, 23 (8) : 879.
  • 2Gasche Y, Fujimura M, Morita Fujimuro Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice:a possible rote in blood-brain barrier dysfunction. J Cereb Blood Flow Metab, 1999, 19(9): 1020.
  • 3Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinttse expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke, 2001, 32(8) : 1759.
  • 4Hamann GF. Unriddling the role of matrix metalloproteinases in human cerebral stroke. Stroke, 2003, 34(1): 40.
  • 5Lima JE, Takayanagui OM, Garcia LV, et al. Use of neuron-specific enolase for assessing the severity and outcome of neurological disorders inpatients. Braz J Med Biol Res, 2004, 37(1):19.
  • 6Hermmnn M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci, 2003, 21(3-4): 177.
  • 7Montaner J, Alvarez-Sabin J, Molina CA, et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke, 2001, 32(12): 2762.
  • 8Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke, 1998, 29(10): 2189.

共引文献47

同被引文献23

  • 1段辽江,齐中华,李胜.出血性脑梗死52例临床分析[J].大连医科大学学报,2007,29(2):151-152. 被引量:11
  • 2Mintz GS.Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound[J].Am J Cardiol,2007,100(8B):26M-35M.
  • 3Mitra AK,Agrawal DK.In stent restenosis:bane of the stent era[J].J Clin Pathol,2006,59(3):232-239.
  • 4Teirstein PS,Massullo V,Jani S,et al.Catheter-based radiotherapy to inhibit restenosis after coronary stenting[J].N Engl J Med,1997,336:1697-1703.
  • 5Schartl M,Bocksch W.How to assess coronary artery remodeling by intravascular ultrasound[J].Am Heart J,2006,152(3):414-416.
  • 6Bonello L,De Labriolle A,Lemesle G,et al.Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice[J].Arch Cardiovasc Dis,2009,102(2):143-151.
  • 7Katsaros KM,Kastl SP,Zorn G,et al.Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9[J].JACC Cardiovasc Interv,2010,3(1):90-97.
  • 8Raffetto JD,Khalil RA.Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease[J].Biochem Pharmacol,2008,75(2):346-359.
  • 9Lalu MM,Pasini E,Schulze CJ,et al.Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart[J].Eur Heart J,2005,26(1):27-35.
  • 10Jones GT,Tarr GP,Phillips LV,et al.Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis[J].Atherosclerosis,2009,207(2):603-607.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部